Insider Trading & Ownership of Juvenescence US Corp.

Location: Princeton, NJ
Summary: The estimated value of insider holdings of Juvenescence US Corp. is at least $9,704,025 dollars as of 22 Mar 2023. Juvenescence US Corp. is the Director, 10%+ Owner of AgeX Therapeutics, Inc. and owns shares of Serina Therapeutics, Inc. (SER) stock worth about $9.7M.
Signature: /s/ David Gill, Vice President and Treasurer
All Insider Reports: All Insider Reports

Notify me when Juvenescence US Corp. files a new Insider Trading report.

Ownership of Juvenescence US Corp.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SER	AgeX Therapeutics, Inc.	Director, 10%+ Owner	$9,704,025			14 Mar 2023